ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers

Part of paid clinical trials in New York, New York.

Sponsor
Columbia University
Study ID
NCT04367857
Status
Recruiting
Apply to this trial

Conditions

  • Coronavirus
  • Coronavirus Infection
  • Covid-19

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • COVID-19 Serology — OTHER
    Quantitate Serology enzyme-linked immunosorbent assay (ELISA) for COVID-19
  • Health Care Worker Survey — BEHAVIORAL
    The purpose of this survey is to assess how healthcare workers are experiencing and coping with the COVID-19 crisis.

Study Details

The novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders in the COVID-19 crisis. The investigators will look at different ways to measure how common COVID-19 is among health care workers, how common is the presence of antibodies by serological tests (also known as serostatus). The investigators will describe health worker mental and emotional well-being and their coping strategies in their institutional settings. Lastly, the investigators will describe how knowing serostatus can affect individuals' mental and emotional well-being and how to cope in the midst of the COVID-19 response. This will help to how to better test and help healthcare workers in the COVID-19 pandemic and prepare for possible future outbreaks.

Key Dates

Start date
Apr 18, 2020
Status verified
Apr 2026
Primary completion
Feb 28, 2027
Completion
Feb 28, 2027

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Prior Positive polymerase chain reaction (PCR) and Recovered
    Prior Positive PCR result, fully recovered, back at work and symptom free for greater than or equal than 14 days.
  • Arm: Never tested, history of COVID-19 Symptoms and Recovered
    Never tested and history of COVID-19 symptoms and symptom-free for more than 14 days
  • Arm: Never tested and current COVID-19 Symptoms
    Never tested and current COVID-19 Symptoms (e.g. referred by a provider or clinic)
  • Arm: Never tested and asymptomatic
    Never tested and asymptomatic for COVID-19 symptoms, including asymptomatic health care worker

Primary Outcome Measure

Proportion seropositive [ Time Frame: Up to 12 months after collection visit ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NewYork-Presbyterian Hosptial/Columbia University Irving Medical CenterNew YorkNew York10032
Brett Gray

Find similar trials in New York, NY

By condition
COVID-19 / long COVID
By specialty
Infectious disease
By research site
NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center· New York, NY

Related Studies